iiinova — where your digital self keeps evolving

Arpaia Lab @arpaialab.bsky.social · 17/09/2026

Subscription DOI link: doi.org/10.1126/scit...

Arpaia Lab @arpaialab.bsky.social · 17/09/2026

New paper from our lab, out today in Science Translational Medicine! 🎉 Zaofeng Yang & team engineer a probiotic platform combining enzyme/prodrug chemo (CD/5-FC → 5-FU) with IL-15 + PD-L1 blockade, driving durable antitumor immunity! Free access: tinyurl.com/2k8c8axu

tinyurl.com

Engineered probiotics for tumor-targeted combination chemoimmunotherapy

A precision-engineered bacterial platform integrates enzyme/prodrug chemotherapy and immunotherapy to drive synergistic antitumor responses.

110

Arpaia Lab @arpaialab.bsky.social · 12/09/2026

Fantastic feature on bacteria-based cancer therapies by Liam Drew in Nature! 🧫 Salmonella + IL-2 (Saltzman), tetanus-toxin Listeria (Gravekamp), self-destructing bacteria (Forbes), programmable circuits (Danino) – our work is part of this story too! 🦠 youtu.be/lYuGzWGusuU

youtu.be

A new way to target cancer

YouTube video by nature video

100

Reposted by Arpaia Lab

NCI CIP-Net @nci-cipnet.org · 03/09/2026

🎙️ CIP-Net Podcast Episode 1 is live! Drs. Bodour Salhia and Robert Samstein discuss the emerging science of cancer immunoprevention and how the immune system could help prevent cancer before it develops. 🎧 Listen now: www.nci-cipnet.org/en/news-podc...

011

Reposted by Arpaia Lab

NCI CIP-Net @nci-cipnet.org · 01/09/2026

What is cancer immunoprevention and how does it work? The #CIPNet Community Engagement Working Group created this infographic to make the science of cancer immunoprevention more accessible to everyone. 📥 Download it, share it, and help us spread the knowledge! #CancerImmunotherapy #CancerPrevention

021

Reposted by Arpaia Lab

Waggoner Lab @labwaggoner.bsky.social · 11/08/2026

A novel CAF population coordinates hyper-suppressive regulatory T cell recruitment and localization in lung cancer @natimmunol.nature.com @arpaialab.bsky.social @columbiauniversity.bsky.social www.nature.com/articles/s41...

041

Reposted by Arpaia Lab

Waggoner Lab @labwaggoner.bsky.social · 22/07/2026

Intravesically delivered engineered bacteria promote PD-1 blockade efficacy in aggressive murine models of bladder cancer www.science.org/doi/10.1126/... @columbiauniversity.bsky.social @arpaialab.bsky.social

121

Arpaia Lab @arpaialab.bsky.social · 21/05/2025

The Arpaia Lab is currently recruiting for a Staff Associate I position 🧑‍🔬. Please share the following job description and application link with anyone you believe would be interested. Thank you! apply.interfolio.com/167245

010